logo

For the Inventor, By the Inventor

Tokushima, Japan

Yasuo Yanagihara

This inventor holds 10 USPTO granted patents and 1 EPO patent. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 1990-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yasuo Yanagihara. Retrieved from https://idiyas.com/inventor/yasuo-yanagihara

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 10

% Patents Active = 70.0


Average Co-Inventor Count = 10.7

ph-index = 4

Forward Citations = 40(Granted Patents)


Location History:

  • Tokushima, JP (1990 - 2000)
  • Otsu, JP (2012)
  • Osaka, JP (2014)

Company Filing History:

goldMedal10 out of 846 
 
Otsuka Pharmaceutical Company, Limited
 patents

Years Active: 1990-2014

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents
1. 8722663 - Di-substituted pyridine derivatives as anticancers (2014-05-13),
2. 8263599 - STAT3/5 activation inhibitor (2012-09-11),
3. 8188277 - Aromatic compounds for suppressing the generation of collagen (2012-05-29),
4. 6107465 - IL-1.beta. and derivatives thereof and drugs (2000-08-22),
5. 5847098 - DNA encoding interleukin IL-1.beta. mutant (1998-12-08),
6. 5702698 - Methods of use of IL-1.alpha. (1997-12-30),
7. 5543140 - Method and use of IL-1.alpha. (1996-08-06),
8. 5371204 - Gene that encodes for polypeptides of IL-1.alpha. (1994-12-06),
9. 5008374 - IL-1.alpha. derivatives and drugs (1991-04-16),
10. 4898818 - Antitumor active substance, process for preparing the same, drug (1990-02-06),

Title: Innovations and Contributions of Yasuo Yanagihara

Introduction

Yasuo Yanagihara is a prominent inventor based in Tokushima, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds with potential therapeutic applications. With a total of 10 patents to his name, Yanagihara's work focuses on innovative solutions for cancer treatment and other medical conditions.

Latest Patents

One of his latest patents involves di-substituted pyridine derivatives as anticancer agents. This invention presents a novel compound that exhibits an excellent antitumor effect. The compound is represented by a specific general formula, where various components are defined to enhance its efficacy. Another significant patent is a STAT3/5 activation inhibitor, which aims to provide a solution for inhibiting the activation of these critical signaling pathways. This invention includes an aromatic compound as an active ingredient, showcasing Yanagihara's expertise in medicinal chemistry.

Career Highlights

Yasuo Yanagihara is currently associated with Otsuka Pharmaceutical Company, Limited, where he continues to innovate and develop new pharmaceutical products. His work has been instrumental in advancing the company's research initiatives and enhancing its product portfolio. Yanagihara's dedication to his field is evident through his numerous patents and ongoing research efforts.

Collaborations

Throughout his career, Yanagihara has collaborated with notable colleagues, including Satoru Nakai and Mayumi Kaneta. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the development of groundbreaking inventions.

Conclusion

Yasuo Yanagihara's contributions to the field of pharmaceuticals are noteworthy, particularly in the area of cancer treatment. His innovative patents and collaborations reflect his commitment to advancing medical science and improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…